Ironwood Pharmaceuticals, Inc. (IRWD)
3.96
-0.65
(-14.10%)
USD |
NASDAQ |
Feb 20, 16:00
3.96
0.00 (0.00%)
Pre-Market: 20:00
Ironwood Pharmaceuticals SG&A Expense (Quarterly) : 21.91M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 3.895B |
| Outlook Therapeutics, Inc. | 8.612M |
| Nektar Therapeutics | 16.07M |
| Rigel Pharmaceuticals, Inc. | 28.94M |
| CorMedix, Inc. | 36.64M |